{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T14:41:54Z","timestamp":1761489714360},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,7,8]],"date-time":"2015-07-08T00:00:00Z","timestamp":1436313600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12885-015-1522-4","type":"journal-article","created":{"date-parts":[[2015,7,7]],"date-time":"2015-07-07T07:50:55Z","timestamp":1436255455000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Comparative microRNA profiling of sporadic and BRCA1 associated basal-like breast cancers"],"prefix":"10.1186","volume":"15","author":[{"name":"kConFab Investigators, kConFab","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Max","family":"Yan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristy","family":"Shield-Artin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Byrne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siddhartha","family":"Deb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nic","family":"Waddell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Izhak","family":"Haviv","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen B","family":"Fox","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,7,8]]},"reference":[{"issue":"6","key":"1522_CR1","doi-asserted-by":"publisher","first-page":"1991","DOI":"10.1016\/S0002-9440(10)64476-8","volume":"161","author":"M Rijn van de","year":"2002","unstructured":"van de Rijn M, Perou CM, Tibshirani R, Haas P, Kallioniemi O, Kononen J, et al. Expression of cytokeratins 17 and 5 identifies a group of breast carcinomas with poor clinical outcome. Am J Pathol. 2002;161(6):1991\u20136.","journal-title":"Am J Pathol"},{"issue":"1","key":"1522_CR2","doi-asserted-by":"publisher","first-page":"R4","DOI":"10.1186\/bcr1636","volume":"9","author":"LG Fulford","year":"2007","unstructured":"Fulford LG, Reis-Filho JS, Ryder K, Jones C, Gillett CE, Hanby A, et al. Basal-like grade III invasive ductal carcinoma of the breast: patterns of metastasis and long-term survival. Breast Cancer Res. 2007;9(1):R4.","journal-title":"Breast Cancer Res"},{"issue":"16","key":"1522_CR3","doi-asserted-by":"publisher","first-page":"5367","DOI":"10.1158\/1078-0432.CCR-04-0220","volume":"10","author":"TO Nielsen","year":"2004","unstructured":"Nielsen TO, Hsu FD, Jensen K, Cheang M, Karaca G, Hu Z, et al. Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma. Clin Cancer Res. 2004;10(16):5367\u201374.","journal-title":"Clin Cancer Res"},{"issue":"5","key":"1522_CR4","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1158\/1078-0432.CCR-05-2281","volume":"12","author":"SM Rodriguez-Pinilla","year":"2006","unstructured":"Rodriguez-Pinilla SM, Sarrio D, Honrado E, Hardisson D, Calero F, Benitez J, et al. Prognostic significance of basal-like phenotype and fascin expression in node-negative invasive breast carcinomas. Clin Cancer Res. 2006;12(5):1533\u20139.","journal-title":"Clin Cancer Res"},{"issue":"14","key":"1522_CR5","doi-asserted-by":"publisher","first-page":"5175","DOI":"10.1158\/1078-0432.CCR-04-2424","volume":"11","author":"SR Lakhani","year":"2005","unstructured":"Lakhani SR, Reis-Filho JS, Fulford L, Penault-Llorca F, van der Vijver M, Parry S, et al. Prediction of BRCA1 status in patients with breast cancer using estrogen receptor and basal phenotype. Clin Cancer Res. 2005;11(14):5175\u201380.","journal-title":"Clin Cancer Res"},{"issue":"19","key":"1522_CR6","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1093\/jnci\/djg050","volume":"95","author":"WD Foulkes","year":"2003","unstructured":"Foulkes WD, Stefansson IM, Chappuis PO, Begin LR, Goffin JR, Wong N, et al. Germline BRCA1 mutations and a basal epithelial phenotype in breast cancer. J Natl Cancer Inst. 2003;95(19):1482\u20135.","journal-title":"J Natl Cancer Inst"},{"issue":"2","key":"1522_CR7","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","volume":"116","author":"DP Bartel","year":"2004","unstructured":"Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004;116(2):281\u201397.","journal-title":"Cell"},{"issue":"5589","key":"1522_CR8","doi-asserted-by":"publisher","first-page":"2056","DOI":"10.1126\/science.1073827","volume":"297","author":"G Hutvagner","year":"2002","unstructured":"Hutvagner G, Zamore PD. A microRNA in a multiple-turnover RNAi enzyme complex. Science. 2002;297(5589):2056\u201360.","journal-title":"Science"},{"issue":"46","key":"1522_CR9","doi-asserted-by":"publisher","first-page":"6163","DOI":"10.1038\/sj.onc.1209909","volume":"25","author":"BM Engels","year":"2006","unstructured":"Engels BM, Hutvagner G. Principles and effects of microRNA-mediated post-transcriptional gene regulation. Oncogene. 2006;25(46):6163\u20139.","journal-title":"Oncogene"},{"issue":"2","key":"1522_CR10","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1006\/dbio.1999.9523","volume":"216","author":"PH Olsen","year":"1999","unstructured":"Olsen PH, Ambros V. The lin-4 regulatory RNA controls developmental timing in Caenorhabditis elegans by blocking LIN-14 protein synthesis after the initiation of translation. Dev Biol. 1999;216(2):671\u201380.","journal-title":"Dev Biol"},{"issue":"4","key":"1522_CR11","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/j.molcel.2006.01.031","volume":"21","author":"CP Petersen","year":"2006","unstructured":"Petersen CP, Bordeleau ME, Pelletier J, Sharp PA. Short RNAs repress translation after initiation in mammalian cells. Mol Cell. 2006;21(4):533\u201342.","journal-title":"Mol Cell"},{"issue":"10","key":"1522_CR12","doi-asserted-by":"publisher","first-page":"R214","DOI":"10.1186\/gb-2007-8-10-r214","volume":"8","author":"C Blenkiron","year":"2007","unstructured":"Blenkiron C, Goldstein LD, Thorne NP, Spiteri I, Chin SF, Dunning MJ, et al. MicroRNA expression profiling of human breast cancer identifies new markers of tumor subtype. Genome Biol. 2007;8(10):R214.","journal-title":"Genome Biol"},{"issue":"12","key":"1522_CR13","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1038\/modpathol.2010.177","volume":"23","author":"EA Janssen","year":"2010","unstructured":"Janssen EA, Slewa A, Gudlaugsson E, Jonsdottir K, Skaland I, Soiland H, et al. Biologic profiling of lymph node negative breast cancers by means of microRNA expression. Mod Pathol. 2010;23(12):1567\u201376.","journal-title":"Mod Pathol"},{"issue":"2","key":"1522_CR14","doi-asserted-by":"publisher","first-page":"e16915","DOI":"10.1371\/journal.pone.0016915","volume":"6","author":"E Enerly","year":"2011","unstructured":"Enerly E, Steinfeld I, Kleivi K, Leivonen SK, Aure MR, Russnes HG, et al. miRNA-mRNA integrated analysis reveals roles for miRNAs in primary breast tumors. PLoS One. 2011;6(2):e16915.","journal-title":"PLoS One"},{"key":"1522_CR15","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1186\/1471-2164-14-643","volume":"14","author":"E Rinaldis de","year":"2013","unstructured":"de Rinaldis E, Gazinska P, Mera A, Modrusan Z, Fedorowicz GM, Burford B, et al. Integrated genomic analysis of triple-negative breast cancers reveals novel microRNAs associated with clinical and molecular phenotypes and sheds light on the pathways they control. BMC Genomics. 2013;14:643.","journal-title":"BMC Genomics"},{"issue":"7449","key":"1522_CR16","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1038\/nature12108","volume":"497","author":"H Dvinge","year":"2013","unstructured":"Dvinge H, Git A, Graf S, Salmon-Divon M, Curtis C, Sottoriva A, et al. The shaping and functional consequences of the microRNA landscape in breast cancer. Nature. 2013;497(7449):378\u201382.","journal-title":"Nature"},{"issue":"1","key":"1522_CR17","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1136\/jcp.2008.058339","volume":"62","author":"U Siebolts","year":"2009","unstructured":"Siebolts U, Varnholt H, Drebber U, Dienes HP, Wickenhauser C, Odenthal M. Tissues from routine pathology archives are suitable for microRNA analyses by quantitative PCR. J Clin Pathol. 2009;62(1):84\u20138.","journal-title":"J Clin Pathol"},{"issue":"3","key":"1522_CR18","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1261\/rna.1295509","volume":"15","author":"S Pradervand","year":"2009","unstructured":"Pradervand S, Weber J, Thomas J, Bueno M, Wirapati P, Lefort K, et al. Impact of normalization on miRNA microarray expression profiling. RNA. 2009;15(3):493\u2013501.","journal-title":"RNA"},{"issue":"7175","key":"1522_CR19","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1038\/nature06487","volume":"451","author":"SF Tavazoie","year":"2008","unstructured":"Tavazoie SF, Alarcon C, Oskarsson T, Padua D, Wang Q, Bos PD, et al. Endogenous human microRNAs that suppress breast cancer metastasis. Nature. 2008;451(7175):147\u201352.","journal-title":"Nature"},{"issue":"2","key":"1522_CR20","doi-asserted-by":"publisher","first-page":"287","DOI":"10.2144\/05382RR05","volume":"38","author":"V Luu-The","year":"2005","unstructured":"Luu-The V, Paquet N, Calvo E, Cumps J. Improved real-time RT-PCR method for high-throughput measurements using second derivative calculation and double correction. Biotechniques. 2005;38(2):287\u201393.","journal-title":"Biotechniques"},{"issue":"7209","key":"1522_CR21","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1038\/nature07228","volume":"455","author":"M Selbach","year":"2008","unstructured":"Selbach M, Schwanhausser B, Thierfelder N, Fang Z, Khanin R, Rajewsky N. Widespread changes in protein synthesis induced by microRNAs. Nature. 2008;455(7209):58\u201363.","journal-title":"Nature"},{"issue":"49","key":"1522_CR22","doi-asserted-by":"publisher","first-page":"19291","DOI":"10.1073\/pnas.0709971104","volume":"104","author":"FV Karginov","year":"2007","unstructured":"Karginov FV, Conaco C, Xuan Z, Schmidt BH, Parker JS, Mandel G, et al. A biochemical approach to identifying microRNA targets. Proc Natl Acad Sci U S A. 2007;104(49):19291\u20136.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"1522_CR23","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1007\/s10549-009-0653-1","volume":"123","author":"N Waddell","year":"2010","unstructured":"Waddell N, Arnold J, Cocciardi S, da Silva L, Marsh A, Riley J, et al. Subtypes of familial breast tumours revealed by expression and copy number profiling. Breast Cancer Res Treat. 2010;123(3):661\u201377.","journal-title":"Breast Cancer Res Treat"},{"issue":"7","key":"1522_CR24","doi-asserted-by":"publisher","first-page":"1976","DOI":"10.1158\/1078-0432.CCR-07-4100","volume":"14","author":"K Aaltonen","year":"2008","unstructured":"Aaltonen K, Blomqvist C, Amini RM, Eerola H, Aittomaki K, Heikkila P, et al. Familial breast cancers without mutations in BRCA1 or BRCA2 have low cyclin E and high cyclin D1 in contrast to cancers in BRCA mutation carriers. Clin Cancer Res. 2008;14(7):1976\u201383.","journal-title":"Clin Cancer Res"},{"issue":"8","key":"1522_CR25","first-page":"2011","volume":"59","author":"JE Armes","year":"1999","unstructured":"Armes JE, Trute L, White D, Southey MC, Hammet F, Tesoriero A, et al. Distinct molecular pathogeneses of early-onset breast cancers in BRCA1 and BRCA2 mutation carriers: a population-based study. Cancer Res. 1999;59(8):2011\u20137.","journal-title":"Cancer Res"},{"issue":"10","key":"1522_CR26","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1136\/jcp.2009.065169","volume":"62","author":"M Rayoo","year":"2009","unstructured":"Rayoo M, Yan M, Takano EA, Bates GJ, Brown PJ, Banham AH, et al. Expression of the forkhead box transcription factor FOXP1 is associated with oestrogen receptor alpha, oestrogen receptor beta and improved survival in familial breast cancers. J Clin Pathol. 2009;62(10):896\u2013902.","journal-title":"J Clin Pathol"},{"issue":"2","key":"1522_CR27","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1007\/s10549-010-0941-9","volume":"126","author":"M Yan","year":"2011","unstructured":"Yan M, Rayoo M, Takano EA, Fox SB. Nuclear and cytoplasmic expressions of ERbeta1 and ERbeta2 are predictive of response to therapy and alters prognosis in familial breast cancers. Breast Cancer Res Treat. 2011;126(2):395\u2013405.","journal-title":"Breast Cancer Res Treat"},{"issue":"7","key":"1522_CR28","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1038\/sj.bjc.6605287","volume":"101","author":"M Yan","year":"2009","unstructured":"Yan M, Rayoo M, Takano EA, Investigators KC, Fox SB. BRCA1 tumours correlate with a HIF-1alpha phenotype and have a poor prognosis through modulation of hydroxylase enzyme profile expression. Br J Cancer. 2009;101(7):1168\u201374.","journal-title":"Br J Cancer"},{"issue":"2","key":"1522_CR29","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/sj.bjc.6604844","volume":"100","author":"EY Tan","year":"2009","unstructured":"Tan EY, Yan M, Campo L, Han C, Takano E, Turley H, et al. The key hypoxia regulated gene CAIX is upregulated in basal-like breast tumours and is associated with resistance to chemotherapy. Br J Cancer. 2009;100(2):405\u201311.","journal-title":"Br J Cancer"},{"issue":"1","key":"1522_CR30","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1158\/1055-9965.EPI-11-0775","volume":"21","author":"N Mavaddat","year":"2012","unstructured":"Mavaddat N, Barrowdale D, Andrulis IL, Domchek SM, Eccles D, Nevanlinna H, et al. Pathology of breast and ovarian cancers among BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1\/2 (CIMBA). Cancer Epidemiol Biomark Prev. 2012;21(1):134\u201347.","journal-title":"Cancer Epidemiol Biomark Prev"},{"issue":"6797","key":"1522_CR31","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1038\/35021093","volume":"406","author":"CM Perou","year":"2000","unstructured":"Perou CM, Sorlie T, Eisen MB, van de Rijn M, Jeffrey SS, Rees CA, et al. Molecular portraits of human breast tumours. Nature. 2000;406(6797):747\u201352.","journal-title":"Nature"},{"issue":"4","key":"1522_CR32","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1038\/nm.3497","volume":"20","author":"JK Mouw","year":"2014","unstructured":"Mouw JK, Yui Y, Damiano L, Bainer RO, Lakins JN, Acerbi I, et al. Tissue mechanics modulate microRNA-dependent PTEN expression to regulate malignant progression. Nat Med. 2014;20(4):360\u20137.","journal-title":"Nat Med"},{"issue":"5","key":"1522_CR33","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.3892\/or.2013.2691","volume":"30","author":"MA Fonseca-Sanchez","year":"2013","unstructured":"Fonseca-Sanchez MA, Perez-Plasencia C, Fernandez-Retana J, Arechaga-Ocampo E, Marchat LA, Rodriguez-Cuevas S, et al. microRNA-18b is upregulated in breast cancer and modulates genes involved in cell migration. Oncol Rep. 2013;30(5):2399\u2013410.","journal-title":"Oncol Rep"},{"issue":"8","key":"1522_CR34","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1038\/onc.2011.296","volume":"31","author":"K Kim","year":"2012","unstructured":"Kim K, Chadalapaka G, Lee SO, Yamada D, Sastre-Garau X, Defossez PA, et al. Identification of oncogenic microRNA-17-92\/ZBTB4\/specificity protein axis in breast cancer. Oncogene. 2012;31(8):1034\u201344.","journal-title":"Oncogene"},{"issue":"1","key":"1522_CR35","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1038\/onc.2013.525","volume":"34","author":"C Gong","year":"2015","unstructured":"Gong C, Qu S, Liu B, Pan S, Jiao Y, Nie Y, et al. MiR-106b expression determines the proliferation paradox of TGF-beta in breast cancer cells. Oncogene. 2015;34(1):84\u201393.","journal-title":"Oncogene"},{"issue":"12","key":"1522_CR36","doi-asserted-by":"publisher","first-page":"e83083","DOI":"10.1371\/journal.pone.0083083","volume":"8","author":"Y Liu","year":"2013","unstructured":"Liu Y, Li H, Feng J, Cui X, Huang W, Li Y, et al. Lin28 induces epithelial-to-mesenchymal transition and stemness via downregulation of let-7a in breast cancer cells. PLoS One. 2013;8(12):e83083.","journal-title":"PLoS One"},{"issue":"4","key":"1522_CR37","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1093\/jnci\/djj052","volume":"98","author":"C Sotiriou","year":"2006","unstructured":"Sotiriou C, Wirapati P, Loi S, Harris A, Fox S, Smeds J, et al. Gene expression profiling in breast cancer: understanding the molecular basis of histologic grade to improve prognosis. J Natl Cancer Inst. 2006;98(4):262\u201372.","journal-title":"J Natl Cancer Inst"},{"issue":"7","key":"1522_CR38","doi-asserted-by":"publisher","first-page":"e6146","DOI":"10.1371\/journal.pone.0006146","volume":"4","author":"J Kao","year":"2009","unstructured":"Kao J, Salari K, Bocanegra M, Choi YL, Girard L, Gandhi J, et al. Molecular profiling of breast cancer cell lines defines relevant tumor models and provides a resource for cancer gene discovery. PLoS One. 2009;4(7):e6146.","journal-title":"PLoS One"},{"issue":"5","key":"1522_CR39","doi-asserted-by":"publisher","first-page":"R65","DOI":"10.1186\/bcr1771","volume":"9","author":"B Kreike","year":"2007","unstructured":"Kreike B, van Kouwenhove M, Horlings H, Weigelt B, Peterse H, Bartelink H, et al. Gene expression profiling and histopathological characterization of triple-negative\/basal-like breast carcinomas. Breast Cancer Res. 2007;9(5):R65.","journal-title":"Breast Cancer Res"},{"issue":"3","key":"1522_CR40","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1038\/ni1169","volume":"6","author":"C Vliet van","year":"2005","unstructured":"van Vliet C, Bukczynska PE, Puryer MA, Sadek CM, Shields BJ, Tremblay ML, et al. Selective regulation of tumor necrosis factor-induced Erk signaling by Src family kinases and the T cell protein tyrosine phosphatase. Nat Immunol. 2005;6(3):253\u201360.","journal-title":"Nat Immunol"},{"issue":"17","key":"1522_CR41","doi-asserted-by":"publisher","first-page":"17203","DOI":"10.1074\/jbc.M500077200","volume":"280","author":"Y Takada","year":"2005","unstructured":"Takada Y, Kobayashi Y, Aggarwal BB. Evodiamine abolishes constitutive and inducible NF-kappaB activation by inhibiting IkappaBalpha kinase activation, thereby suppressing NF-kappaB-regulated antiapoptotic and metastatic gene expression, up-regulating apoptosis, and inhibiting invasion. J Biol Chem. 2005;280(17):17203\u201312.","journal-title":"J Biol Chem"},{"issue":"7","key":"1522_CR42","doi-asserted-by":"publisher","first-page":"4626","DOI":"10.1074\/jbc.M808490200","volume":"284","author":"A Jurek","year":"2009","unstructured":"Jurek A, Amagasaki K, Gembarska A, Heldin CH, Lennartsson J. Negative and positive regulation of MAPK phosphatase 3 controls platelet-derived growth factor-induced Erk activation. J Biol Chem. 2009;284(7):4626\u201334.","journal-title":"J Biol Chem"},{"issue":"52","key":"1522_CR43","doi-asserted-by":"publisher","first-page":"52154","DOI":"10.1074\/jbc.M307299200","volume":"278","author":"RK Lo","year":"2003","unstructured":"Lo RK, Cheung H, Wong YH. Constitutively active Galpha16 stimulates STAT3 via a c-Src\/JAK- and ERK-dependent mechanism. J Biol Chem. 2003;278(52):52154\u201365.","journal-title":"J Biol Chem"},{"issue":"1","key":"1522_CR44","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/s10549-009-0621-9","volume":"123","author":"B Cohen","year":"2010","unstructured":"Cohen B, Shimizu M, Izrailit J, Ng NF, Buchman Y, Pan JG, et al. Cyclin D1 is a direct target of JAG1-mediated Notch signaling in breast cancer. Breast Cancer Res Treat. 2010;123(1):113\u201324.","journal-title":"Breast Cancer Res Treat"},{"issue":"35","key":"1522_CR45","doi-asserted-by":"publisher","first-page":"5060","DOI":"10.1038\/sj.onc.1210319","volume":"26","author":"K Kehn","year":"2007","unstructured":"Kehn K, Berro R, Alhaj A, Bottazzi ME, Yeh WI, Klase Z, et al. Functional consequences of cyclin D1\/BRCA1 interaction in breast cancer cells. Oncogene. 2007;26(35):5060\u20139.","journal-title":"Oncogene"},{"issue":"2","key":"1522_CR46","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/s00262-013-1500-0","volume":"63","author":"B Chaudhary","year":"2014","unstructured":"Chaudhary B, Khaled YS, Ammori BJ, Elkord E. Neuropilin 1: function and therapeutic potential in cancer. Cancer Immunol Immunother. 2014;63(2):81\u201399.","journal-title":"Cancer Immunol Immunother"},{"issue":"44","key":"1522_CR47","doi-asserted-by":"publisher","first-page":"17079","DOI":"10.1073\/pnas.0806092105","volume":"105","author":"S Rottenberg","year":"2008","unstructured":"Rottenberg S, Jaspers JE, Kersbergen A, van der Burg E, Nygren AO, Zander SA, et al. High sensitivity of BRCA1-deficient mammary tumors to the PARP inhibitor AZD2281 alone and in combination with platinum drugs. Proc Natl Acad Sci U S A. 2008;105(44):17079\u201384.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"Suppl 8","key":"1522_CR48","doi-asserted-by":"publisher","first-page":"viii13","DOI":"10.1093\/annonc\/mdt306","volume":"24","author":"S Summa De","year":"2013","unstructured":"De Summa S, Pinto R, Sambiasi D, Petriella D, Paradiso V, Paradiso A, et al. BRCAness: a deeper insight into basal-like breast tumors. Ann Oncol. 2013;24 Suppl 8:viii13\u201321.","journal-title":"Ann Oncol"},{"issue":"3","key":"1522_CR49","doi-asserted-by":"publisher","first-page":"R27","DOI":"10.1186\/bcr2257","volume":"11","author":"AJ Lowery","year":"2009","unstructured":"Lowery AJ, Miller N, Devaney A, McNeill RE, Davoren PA, Lemetre C, et al. MicroRNA signatures predict oestrogen receptor, progesterone receptor and HER2\/neu receptor status in breast cancer. Breast Cancer Res. 2009;11(3):R27.","journal-title":"Breast Cancer Res"},{"issue":"12","key":"1522_CR50","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1038\/modpathol.2010.177","volume":"23","author":"EA Janssen","year":"2010","unstructured":"Janssen EA, Slewa A, Gudlaugsson E, Jonsdottir K, Skaland I, Soiland H, et al. Biologic profiling of lymph node negative breast cancers by means of microRNA expression. Mod Pathol. 2010;23(12):1567\u201376.","journal-title":"Mod Pathol"},{"issue":"2","key":"1522_CR51","doi-asserted-by":"crossref","first-page":"563","DOI":"10.3892\/ijo.2013.2197","volume":"44","author":"R Sandhu","year":"2014","unstructured":"Sandhu R, Rivenbark AG, Mackler RM, Livasy CA, Coleman WB. Dysregulation of microRNA expression drives aberrant DNA hypermethylation in basal-like breast cancer. Int J Oncol. 2014;44(2):563\u201372.","journal-title":"Int J Oncol"},{"issue":"11","key":"1522_CR52","doi-asserted-by":"publisher","first-page":"e48692","DOI":"10.1371\/journal.pone.0048692","volume":"7","author":"K Jonsdottir","year":"2012","unstructured":"Jonsdottir K, Janssen SR, Da Rosa FC, Gudlaugsson E, Skaland I, Baak JP, et al. Validation of expression patterns for nine miRNAs in 204 lymph-node negative breast cancers. PLoS One. 2012;7(11):e48692.","journal-title":"PLoS One"},{"issue":"3","key":"1522_CR53","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1007\/s10549-008-0117-z","volume":"116","author":"SA Joosse","year":"2009","unstructured":"Joosse SA, van Beers EH, Tielen IH, Horlings H, Peterse JL, Hoogerbrugge N, et al. Prediction of BRCA1-association in hereditary non-BRCA1\/2 breast carcinomas with array-CGH. Breast Cancer Res Treat. 2009;116(3):479\u201389.","journal-title":"Breast Cancer Res Treat"},{"issue":"2","key":"1522_CR54","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1002\/gcc.20833","volume":"50","author":"SA Joosse","year":"2011","unstructured":"Joosse SA, Brandwijk KI, Mulder L, Wesseling J, Hannemann J, Nederlof PM. Genomic signature of BRCA1 deficiency in sporadic basal-like breast tumors. Genes Chromosomes Cancer. 2011;50(2):71\u201381.","journal-title":"Genes Chromosomes Cancer"},{"issue":"3","key":"1522_CR55","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1158\/0008-5472.822.65.3","volume":"65","author":"EH Beers van","year":"2005","unstructured":"van Beers EH, van Welsem T, Wessels LF, Li Y, Oldenburg RA, Devilee P, et al. Comparative genomic hybridization profiles in human BRCA1 and BRCA2 breast tumors highlight differential sets of genomic aberrations. Cancer Res. 2005;65(3):822\u20137.","journal-title":"Cancer Res"},{"issue":"17","key":"1522_CR56","doi-asserted-by":"crossref","first-page":"7612","DOI":"10.1158\/0008-5472.CAN-05-0570","volume":"65","author":"G Jonsson","year":"2005","unstructured":"Jonsson G, Naylor TL, Vallon-Christersson J, Staaf J, Huang J, Ward MR, et al. Distinct genomic profiles in hereditary breast tumors identified by array-based comparative genomic hybridization. Cancer Res. 2005;65(17):7612\u201321.","journal-title":"Cancer Res"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12885-015-1522-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-015-1522-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-015-1522-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-015-1522-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,12]],"date-time":"2023-08-12T02:39:43Z","timestamp":1691807983000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-015-1522-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7,8]]},"references-count":56,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["1522"],"URL":"https:\/\/doi.org\/10.1186\/s12885-015-1522-4","relation":{},"ISSN":["1471-2407"],"issn-type":[{"type":"electronic","value":"1471-2407"}],"subject":[],"published":{"date-parts":[[2015,7,8]]},"article-number":"506"}}